Rational PCR Reactor Design in Microfluidics

Area of Science:

• Biotechnology
• Medical Diagnostics
• Biophysics

Background:

• The COVID-19 pandemic accelerated advancements in diagnostic tools, including lateral flow assays (LFA), enzyme-linked immunosorbent assays (ELISA), and polymerase chain reaction (PCR).
• Polymerase chain reaction (PCR) demonstrated significant performance improvements but faces challenges in point-of-care (POC) implementation due to stringent requirements for low limit of detection (LOD), multiplexing, accuracy, selectivity, robustness, and cost.
• A critical clinical need exists for achieving a sample-to-answer time of 10 minutes or less for rapid diagnostics.

Purpose of the Study:

• To introduce three key parameters—overall sample-to-answer time (t), minimum copies per reactor volume (λ), and thermal efficiency (γ)—to guide the design of next-generation PCR reactors.
• To provide a framework for optimizing PCR reactor design for point-of-care applications, addressing limitations of current technologies.

Main Methods:

• Development of three design parameters (t, λ, γ) to guide PCR reactor engineering.
• Numerical simulation of temperature changes within a PCR device to illustrate parameter application.
• Discussion of current commercial and developmental RT-qPCR technologies and their suitability for POC settings.

Main Results:

• The proposed parameters (t, λ, γ) influence critical design aspects including sample volume, reactor scalability, fluidics, reactor geometry, thermal properties, and heating/cooling systems.
• Numerical simulations provide insights into thermal dynamics essential for rapid PCR cycling.
• Analysis highlights the potential and challenges of existing and emerging RT-qPCR technologies for POC use.

Conclusions:

• The defined parameters offer a systematic approach to developing advanced PCR reactors optimized for rapid, efficient point-of-care diagnostics.
• Future PCR reactor designs must integrate considerations of speed, efficiency, and scalability to meet clinical demands for near-instantaneous results.
• Further research and development are needed to overcome current limitations and realize the full potential of RT-qPCR at the point of care.